Some anti-inflammatory properties of ascorbic acid.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001168:Arthritis / Q000517:prevention & control; D001205:Ascorbic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D002351:Carrageenan; D004195:Disease Models, Animal; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D004890:Erythema / Q000517:prevention & control; D005260:Female; D005620:Freund's Adjuvant; D005966:Glucuronidase / Q000037:antagonists & inhibitors; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D014466:Ultraviolet Rays
D000893:Anti-Inflammatory Agents; D002351:Carrageenan; D005620:Freund's Adjuvant; D005966:Glucuronidase; D010653:Phenylbutazone; D001205:Ascorbic Acid; D001241:Aspirin